Multimode Ligand Binding in Receptor Site Modeling: Implementation in CoMFA

Journal of Chemical Information and Computer Sciences

Volumn 43, Issue 6, 2003, Pages 2093-2105

  Lukacova, Viera ^a   Balaz, Stefan ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATIONAL ENERGY; INTERACTION ENERGIES; MULTIMODE LIGAND BINDING;

BINDING ENERGY; COMPLEXATION; COMPOSITION; CONFORMATIONS; REGRESSION ANALYSIS;

MOLECULAR DYNAMICS;

AROMATIC HYDROCARBON RECEPTOR; DRUG RECEPTOR; FURAN DERIVATIVE; LIGAND; POLYCHLORINATED BIPHENYL;

ALGORITHM; ARTICLE; BINDING SITE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; METHODOLOGY; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ALGORITHMS; BINDING SITES; COMPUTATIONAL BIOLOGY; FURANS; LIGANDS; MODELS, MOLECULAR; POLYCHLORINATED BIPHENYLS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, DRUG;

EID: 0345117314     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci034100a     Document Type: Article

References (56)

1. Mattos, C.; Ringe, D. Multiple binding modes. In 3D-QSAR in Drug Design: Theory, Methods, and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 226-254. Balaz, S.; Hornak, V. Multiple binding modes in three-dimensional quantitative structure-activity relationships. In QSAR in Environmental Sciences; Walker, J., Ed.; Society for Environmental Toxicology and Chemistry: Pensacola (in press), de la Paz, P.; Burridge, J. M.; Oatley, S. J.; Blake, C. C. F. Multiple modes of binding of thyroid hormones and other iodothyronines to human plasma transthyretin. In The Design of Drugs to Macromolecular Targets; Bedell, C. R., Ed.; John Wiley and Sons: Chichester, 1992; pp 119-172. Arevalo, J. H.; Hassig, C. A.; Stura, E. A.; Sims, M. J.; Taussig, M. J.; Wilson, I. A. Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes. J. Mol Biol 1994, 241, 663-690.
2. Mattos, C.; Ringe, D. Multiple binding modes. In 3D-QSAR in Drug Design: Theory, Methods, and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 226-254. Balaz, S.; Hornak, V. Multiple binding modes in three-dimensional quantitative structure-activity relationships. In QSAR in Environmental Sciences; Walker, J., Ed.; Society for Environmental Toxicology and Chemistry: Pensacola (in press), de la Paz, P.; Burridge, J. M.; Oatley, S. J.; Blake, C. C. F. Multiple modes of binding of thyroid hormones and other iodothyronines to human plasma transthyretin. In The Design of Drugs to Macromolecular Targets; Bedell, C. R., Ed.; John Wiley and Sons: Chichester, 1992; pp 119-172. Arevalo, J. H.; Hassig, C. A.; Stura, E. A.; Sims, M. J.; Taussig, M. J.; Wilson, I. A. Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes. J. Mol Biol 1994, 241, 663-690.
3. Mattos, C.; Ringe, D. Multiple binding modes. In 3D-QSAR in Drug Design: Theory, Methods, and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 226-254. Balaz, S.; Hornak, V. Multiple binding modes in three-dimensional quantitative structure-activity relationships. In QSAR in Environmental Sciences; Walker, J., Ed.; Society for Environmental Toxicology and Chemistry: Pensacola (in press), de la Paz, P.; Burridge, J. M.; Oatley, S. J.; Blake, C. C. F. Multiple modes of binding of thyroid hormones and other iodothyronines to human plasma transthyretin. In The Design of Drugs to Macromolecular Targets; Bedell, C. R., Ed.; John Wiley and Sons: Chichester, 1992; pp 119-172. Arevalo, J. H.; Hassig, C. A.; Stura, E. A.; Sims, M. J.; Taussig, M. J.; Wilson, I. A. Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes. J. Mol Biol 1994, 241, 663-690.
4. Mattos, C.; Ringe, D. Multiple binding modes. In 3D-QSAR in Drug Design: Theory, Methods, and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 226-254. Balaz, S.; Hornak, V. Multiple binding modes in three-dimensional quantitative structure-activity relationships. In QSAR in Environmental Sciences; Walker, J., Ed.; Society for Environmental Toxicology and Chemistry: Pensacola (in press), de la Paz, P.; Burridge, J. M.; Oatley, S. J.; Blake, C. C. F. Multiple modes of binding of thyroid hormones and other iodothyronines to human plasma transthyretin. In The Design of Drugs to Macromolecular Targets; Bedell, C. R., Ed.; John Wiley and Sons: Chichester, 1992; pp 119-172. Arevalo, J. H.; Hassig, C. A.; Stura, E. A.; Sims, M. J.; Taussig, M. J.; Wilson, I. A. Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes. J. Mol Biol 1994, 241, 663-690.
5. Mattos, C.; Rasmussen, B.; Ding, X.; Petsko, G. A.; Ringe, D. Analogous inhibitors of elastase do not always bind analogously. Nat. Struct. Biol. 1994, 1, 55-58.
6. Lemmen, C.; Zimmermann, M.; Lengauer, T. Multiple molecular superpositioning as an effective tool for virtual database screning. Persp. Drug Discov. Des. 2000, 20, 43-62.
7. Diana, G. D.; Kowalczyk, P.; Treasurywala, R. C. O.; Pevear, D. C.; Dutko, F. J. CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14. J. Med. Chem. 1992, 35, 1002-1008.
8. Oprea, T. I.; Waller, C. L.; Marshall, G. R. Three-dimensional quantitative structure-activity relationship of Human Immunodeficiency Virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes. J. Med. Chem. 1994, 37, 2206-2215.
9. Nicklaus, M. C.; Milne, G. W.; Burke T. R., Jr. QSAR of conformationally flexible molecules: Comparative Molecular Field Analysis of protein-tyrosine kinase inhibitors. J. Comput. Aided Mol. Des. 1992, 6, 487-504.
10. Klebe, G.; Abraham, U. On the prediction of binding properties of drug molecules by Comparative Molecular Field Analysis. J. Med. Chem. 1993, 36, 70-80.
11. Crippen, G. M. Intervals and the deduction of drug binding site models. J. Comput. Chem. 1995, 16, 486-500. Jain, A. N.; Koile, K.; Chapman, D. Compass: Predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark. J. Med. Chem. 1994, 37, 2315-2327.
12. Crippen, G. M. Intervals and the deduction of drug binding site models. J. Comput. Chem. 1995, 16, 486-500. Jain, A. N.; Koile, K.; Chapman, D. Compass: Predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark. J. Med. Chem. 1994, 37, 2315-2327.
13. 30 one-mode 3D-QSAR analyses, which would be done in about 34 years by a fast method consuming only 1 s per analysis.
14. Cramer, R. D., III; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
15. a's) of clonidine-like imidazolines, 2-substituted imidazoles, and 1-methyl-2-substituted imidazoles from 3D-structures using a Comparative Molecular Field Analysis (CoMFA) approach. J. Med. Chem. 1991, 34, 2056-2060.
16. Cramer, R. D., III; Wold, S. Comparative Molecular Field Analysis (CoMFA). U.S. Patent 5, 307, 287, 1994.
17. Hopfinger, A. J.; Wang, S.; Tokarski, J. S.; Jin, B. Q.; Albuquerque, M. ; Madhav, P. J.; Duraiswami, C. Construction of 3D-QSAR models using the 4D-QSAR analysis formalism. J. Am. Chem. Soc. 1997, 119, 10509-10524.
18. Rogers, D.; Hopfinger, A. J. Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationship. J. Chem. Inf. Comput. Sci. 1994, 34, 854-866.
19. Vedani, A.; McMasters, D. R.; Dobler, M. Genetic algorithms in 3DQSAR: The use of multiple ligand orientations for improved predictions of toxicity. Altex 1999, 16, 142-145. Vedani, A.; McMasters, D. R.; Dobler, M. Multi-conformational ligand representation in 4DQSAR: Reducing the bias associated with ligand alignment. Quant. Struct. Act. Relat. 2000, 19, 149-161.
20. Vedani, A.; McMasters, D. R.; Dobler, M. Genetic algorithms in 3DQSAR: The use of multiple ligand orientations for improved predictions of toxicity. Altex 1999, 16, 142-145. Vedani, A.; McMasters, D. R.; Dobler, M. Multi-conformational ligand representation in 4DQSAR: Reducing the bias associated with ligand alignment. Quant. Struct. Act. Relat. 2000, 19, 149-161.
21. Vedani, A.; Briem, K.; Dobler, M.; Dollinger, H.; McMasters, D. R. Multiple-conformation and protonation-state representation in 4DQSAR: The neurokinin-1 receptor system. J. Med. Chem. 2000, 43, 4416-4427.
22. Safe, S.; Sawyer, T.; Mason, G.; Bandiera, S.; Keys, B.; Romkes, M.; Piskorska-Pliszczynska, J.; Zmudzka, B.; Safe, L. Polychlorinated dibenzofurans: Quantitative structure activity relationships. Chemosphere 1985, 14, 675-683.
23. Mason, G.; Sawyer, T.; Keys, B.; Bandiera, S.; Romkes, M.; Piskorska-Pliszczynska, J.; Zmudzka, B.; Safe, S. Polychlorinated dibenzofurans (PCDFs): Correlation between in vivo and in vitro structure-activity relationships. Toxicology 1985, 37, 1-12. Safe, S.; Bandiera, S.; Sawyer, T.; Robertson, L.; Safe, L.; Parkinson, A.; Thomas, P. E.; Ryan, D. E.; Reik, L. M. ; Levin, W. PCBs: Structure-function relationships and mechanism of action. Environ. Health Perspect. 1985, 60, 47-56. Safe, S. Polychlorinated biphenyls (PCBs), dibenzop-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol. 1990, 21, 51-88. Safe, S. H. Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu. Rev. Pharmacol. Toxicol 1986, 26, 371-399.
24. Mason, G.; Sawyer, T.; Keys, B.; Bandiera, S.; Romkes, M.; Piskorska-Pliszczynska, J.; Zmudzka, B.; Safe, S. Polychlorinated dibenzofurans (PCDFs): Correlation between in vivo and in vitro structure-activity relationships. Toxicology 1985, 37, 1-12. Safe, S.; Bandiera, S.; Sawyer, T.; Robertson, L.; Safe, L.; Parkinson, A.; Thomas, P. E.; Ryan, D. E.; Reik, L. M. ; Levin, W. PCBs: Structure-function relationships and mechanism of action. Environ. Health Perspect. 1985, 60, 47-56. Safe, S. Polychlorinated biphenyls (PCBs), dibenzop-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol. 1990, 21, 51-88. Safe, S. H. Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu. Rev. Pharmacol. Toxicol 1986, 26, 371-399.
25. Mason, G.; Sawyer, T.; Keys, B.; Bandiera, S.; Romkes, M.; Piskorska-Pliszczynska, J.; Zmudzka, B.; Safe, S. Polychlorinated dibenzofurans (PCDFs): Correlation between in vivo and in vitro structure-activity relationships. Toxicology 1985, 37, 1-12. Safe, S.; Bandiera, S.; Sawyer, T.; Robertson, L.; Safe, L.; Parkinson, A.; Thomas, P. E.; Ryan, D. E.; Reik, L. M. ; Levin, W. PCBs: Structure-function relationships and mechanism of action. Environ. Health Perspect. 1985, 60, 47-56. Safe, S. Polychlorinated biphenyls (PCBs), dibenzop-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol. 1990, 21, 51-88. Safe, S. H. Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu. Rev. Pharmacol. Toxicol 1986, 26, 371-399.
26. Mason, G.; Sawyer, T.; Keys, B.; Bandiera, S.; Romkes, M.; Piskorska-Pliszczynska, J.; Zmudzka, B.; Safe, S. Polychlorinated dibenzofurans (PCDFs): Correlation between in vivo and in vitro structure-activity relationships. Toxicology 1985, 37, 1-12. Safe, S.; Bandiera, S.; Sawyer, T.; Robertson, L.; Safe, L.; Parkinson, A.; Thomas, P. E.; Ryan, D. E.; Reik, L. M. ; Levin, W. PCBs: Structure-function relationships and mechanism of action. Environ. Health Perspect. 1985, 60, 47-56. Safe, S. Polychlorinated biphenyls (PCBs), dibenzop-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol. 1990, 21, 51-88. Safe, S. H. Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu. Rev. Pharmacol. Toxicol 1986, 26, 371-399.
27. Long, G.; McKinney, J.; Pedersen, L. Polychlorinated dibenzofuran (PCDF) binding to the Ah receptor(s) and associated enzyme induction. Theoretical model based on molecular parameters. Quant. Struct. Act. Relat. 1987, 6, 1-7. Sulea, T.; Kurunczi, L.; Simon, Z. Dioxin-type activity for polyhalogenated arylic derivatives. A QSAR model based on MTD-method. SAR QSAR Environ. Sci. 1995, 3, 37-61. Vedani, A.; McMasters, D. R.; Dobler, M. Genetic algorithms in 3D-QSAR: Predicting the toxicity of dibenzodioxins, dibenzofurans and biphenyls. Altex 1999, 16, 9-14. Mekenyan, O. G.; Veith, G. D.; Call, D. J.; Ankley, G. T. A QSAR evaluation of Ah receptor binding of halogenated aromatic xenobiotics. Environ. Health Perspect. 1996, 104, 1302-1310. Todeschini, R.; Gramatica, P. SD-modelling and prediction by WHIM descriptors. 6. Application of WHIM descriptors in QSAR studies. Quant. Struct. Act. Relat. 1997, 16, 120-125.
28. Long, G.; McKinney, J.; Pedersen, L. Polychlorinated dibenzofuran (PCDF) binding to the Ah receptor(s) and associated enzyme induction. Theoretical model based on molecular parameters. Quant. Struct. Act. Relat. 1987, 6, 1-7. Sulea, T.; Kurunczi, L.; Simon, Z. Dioxin-type activity for polyhalogenated arylic derivatives. A QSAR model based on MTD-method. SAR QSAR Environ. Sci. 1995, 3, 37-61. Vedani, A.; McMasters, D. R.; Dobler, M. Genetic algorithms in 3D-QSAR: Predicting the toxicity of dibenzodioxins, dibenzofurans and biphenyls. Altex 1999, 16, 9-14. Mekenyan, O. G.; Veith, G. D.; Call, D. J.; Ankley, G. T. A QSAR evaluation of Ah receptor binding of halogenated aromatic xenobiotics. Environ. Health Perspect. 1996, 104, 1302-1310. Todeschini, R.; Gramatica, P. SD-modelling and prediction by WHIM descriptors. 6. Application of WHIM descriptors in QSAR studies. Quant. Struct. Act. Relat. 1997, 16, 120-125.
29. Long, G.; McKinney, J.; Pedersen, L. Polychlorinated dibenzofuran (PCDF) binding to the Ah receptor(s) and associated enzyme induction. Theoretical model based on molecular parameters. Quant. Struct. Act. Relat. 1987, 6, 1-7. Sulea, T.; Kurunczi, L.; Simon, Z. Dioxin-type activity for polyhalogenated arylic derivatives. A QSAR model based on MTD-method. SAR QSAR Environ. Sci. 1995, 3, 37-61. Vedani, A.; McMasters, D. R.; Dobler, M. Genetic algorithms in 3D-QSAR: Predicting the toxicity of dibenzodioxins, dibenzofurans and biphenyls. Altex 1999, 16, 9-14. Mekenyan, O. G.; Veith, G. D.; Call, D. J.; Ankley, G. T. A QSAR evaluation of Ah receptor binding of halogenated aromatic xenobiotics. Environ. Health Perspect. 1996, 104, 1302-1310. Todeschini, R.; Gramatica, P. SD-modelling and prediction by WHIM descriptors. 6. Application of WHIM descriptors in QSAR studies. Quant. Struct. Act. Relat. 1997, 16, 120-125.
30. Long, G.; McKinney, J.; Pedersen, L. Polychlorinated dibenzofuran (PCDF) binding to the Ah receptor(s) and associated enzyme induction. Theoretical model based on molecular parameters. Quant. Struct. Act. Relat. 1987, 6, 1-7. Sulea, T.; Kurunczi, L.; Simon, Z. Dioxin-type activity for polyhalogenated arylic derivatives. A QSAR model based on MTD-method. SAR QSAR Environ. Sci. 1995, 3, 37-61. Vedani, A.; McMasters, D. R.; Dobler, M. Genetic algorithms in 3D-QSAR: Predicting the toxicity of dibenzodioxins, dibenzofurans and biphenyls. Altex 1999, 16, 9-14. Mekenyan, O. G.; Veith, G. D.; Call, D. J.; Ankley, G. T. A QSAR evaluation of Ah receptor binding of halogenated aromatic xenobiotics. Environ. Health Perspect. 1996, 104, 1302-1310. Todeschini, R.; Gramatica, P. SD-modelling and prediction by WHIM descriptors. 6. Application of WHIM descriptors in QSAR studies. Quant. Struct. Act. Relat. 1997, 16, 120-125.
31. Long, G.; McKinney, J.; Pedersen, L. Polychlorinated dibenzofuran (PCDF) binding to the Ah receptor(s) and associated enzyme induction. Theoretical model based on molecular parameters. Quant. Struct. Act. Relat. 1987, 6, 1-7. Sulea, T.; Kurunczi, L.; Simon, Z. Dioxin-type activity for polyhalogenated arylic derivatives. A QSAR model based on MTD-method. SAR QSAR Environ. Sci. 1995, 3, 37-61. Vedani, A.; McMasters, D. R.; Dobler, M. Genetic algorithms in 3D-QSAR: Predicting the toxicity of dibenzodioxins, dibenzofurans and biphenyls. Altex 1999, 16, 9-14. Mekenyan, O. G.; Veith, G. D.; Call, D. J.; Ankley, G. T. A QSAR evaluation of Ah receptor binding of halogenated aromatic xenobiotics. Environ. Health Perspect. 1996, 104, 1302-1310. Todeschini, R.; Gramatica, P. SD-modelling and prediction by WHIM descriptors. 6. Application of WHIM descriptors in QSAR studies. Quant. Struct. Act. Relat. 1997, 16, 120-125.
32. Waller, C. L.; McKinney, J. D. Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: Model validation and Ah Receptor characterization. Chem. Res. Toxicol. 1995, 8, 847-858. Waller, C. L.; McKinney, J. D. Comparative Molecular Field Analysis of polyhalogenated dibenzop-dioxins, dibenzofurans, and biphenyls. J. Med. Chem. 1992, 35, 3660-3666.
33. Waller, C. L.; McKinney, J. D. Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: Model validation and Ah Receptor characterization. Chem. Res. Toxicol. 1995, 8, 847-858. Waller, C. L.; McKinney, J. D. Comparative Molecular Field Analysis of polyhalogenated dibenzop-dioxins, dibenzofurans, and biphenyls. J. Med. Chem. 1992, 35, 3660-3666.
34. Balaz, S.; Hornak, V.; Haluska, L. receptor mapping with multiple binding modes: binding site of PCB-degrading dioxygenase. Chemom. Intell. Lab. Sys. 1994, 24, 185-191.
35. Wang, J.; Szewczuk, Z.; Yue, S. Y.; Tsuda, Y.; Konishi, Y.; Purisima, E. O. Calculation of relative binding free energies and configurational entropies: A structural and thermodynamic analysis of the nature of nonpolar binding of thrombin inhibitors based on hirudin55-65. J. Mol. Biol. 1995, 253, 473-492.
36. Hornak, V.; Balaz, S.; Schaper, K. J.; Seydel, J. K. Multiple binding modes in 3D-QSAR: Microbial degradation of polychlorinated biphenyls. Quant. Struct. Act. Relat. 1998, 17, 427-436.
37. Smith, W. R.; Missen, R. W. Chemical Reaction Equilibrium Analysis: Theory and Algorithms; John Wiley and Sons: New York, 1982.
38. Jullien, L.; Proust, A.; LeMenn, J. C. How does the Gibbs free energy evolve in a system undergoing coupled competitive reactions? J. Chem. Educ. 1998, 75, 194-199.
39. In our application example, however, no conformational energy term was needed because the studied compounds do not have rotatable bonds.
40. Balaz, S.; Lukacova, V. Method for drug design using Comparative Molecular Field Analysis extended for multi-mode ligand binding and disposition. U.S. Patent, 2001 (pending).
41. Otherwise, for a small number of C, no linearization would be necessary and nonlinear regression analysis could be adopted using directly eq 4.
42. Henry, E. C.; Gasiewicz, T. A. Transformation of the aryl hydrocarbon receptor to a DNA-binding form is accompanied by release of the 90 kDa heat-shock protein and increased affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. J. 1993, 294, 95-101.
43. Sybyl, version 6.9. Tripos Inc., St. Louis, MO, 2002.
44. Schmidt, M. W.; Baldridge, K. K.; Boatz, J. A.; Elbert, S. T.; Gordon, M. S.; Jensen, J. H.; Koseki, S.; Matsunaga, N.; Nguyen, K. A.; Su, S.; Windus, T. L.; Dupuis, M.; Montgomery, J. A. Jr. General atomic and molecular electronic structure system. J. Comput. Chem. 1993, 14, 1347-1363.
45. Rabinowitz, J. R.; Little, S. B.; Gifford, E. M. Interactions between chlorinated dioxins and a positively charged molecular probe: new molecular interaction potential. J. Comput. Chem. 1998, 19, 673-684.
46. Leon, L. A.; Notario, R.; Quijano, J.; Sanchez, C. Structures and enthalpies of formation in the gas phase of the most toxic polychlorinated dibenzo-p-dioxins. A DFT study. J. Phys. Chem. A 2002, 106, 6618-6627.
47. Pastor, M.; Cruciani, G.; Clementi, S. Smart Region Definition: A new way to improve the predictive ability and interpretability of threedimensional quantitative structure-activity relationships. J. Med. Chem. 1997, 40, 1455-1464. GOLPE, version 4.5. Multivariate Infometric Analysis Sri., Perugia, Italy, 1999.
48. Pastor, M.; Cruciani, G.; Clementi, S. Smart Region Definition: A new way to improve the predictive ability and interpretability of threedimensional quantitative structure-activity relationships. J. Med. Chem. 1997, 40, 1455-1464. GOLPE, version 4.5. Multivariate Infometric Analysis Sri., Perugia, Italy, 1999.
49. The number of included variables or the number of compounds in the set, whichever is smaller.
50. Press: W. H.; Flannery, B. P.; Teukolsky, S. A.; Vetterling, W. T. Numerical Recipes. The Art of Scientific Computing; Cambridge University Press: Cambridge, 1986.
51. The leave-one-out q values for the training set are not used to assess predictive abilities of the models. Predictions for the test set that did not come into contact with calibration are used for this purpose.
52. ijk values that substantially differ from the rest (tested as a difference between mean and median values).
53. Due to the duration of the optimization procedure, predictive ability was examined using a single test set, rather than a series of smaller test sets.
54. Thibaut, U.; Folkers, G.; Klebe, G.; Kubinyi, H.; Merz, A.; Rognan, D. Recommendations for CoMFA studies and 3D QSAR publications. In 3D QSAR in Drug Design, Vol. 1; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 711-716.
55. Since all ligands are planar and aligned in the skeleton plane in all modes, the resulting fields exhibit symmetry about this plane. The analyzed ligand clusters are symmetrical about the y-axis (two modes) and both x- and y-axes (four and, partially, 16 modes). Consequently, the multimode procedure produces equivalent maps, two and four for the two-mode and the four-mode/16-mode approaches, respectively, all rotated by 180° about the corresponding symmetry axes. Each multimode approach arrives at one of the maps depending upon the initial estimates and other details in the optimization procedure.
56. Cramer, R. D. Topomer CoMFA: A design methodology for rapid lead optimization, J. Med. Chem. 2003, 46, 374-388.